Psychotic Symptoms in a Population-Based Sample of 85-Year-Old Individuals With Dementia

Abstract

Psychotic symptoms are common in elderly persons with dementia. These symptoms affect a person’s ability to function in daily life and put strain on the caregiver. Most studies focus on psychotic symptoms in clinical samples with Alzheimer disease (AD). Thus, their prevalence and relation with dementia subtype and severity in very old populations is unclear. We assessed a representative sample of 85-year-old individuals living in Gothenburg, Sweden (n = 494) using neuropsychiatric examinations, key informant interviews, and medical record reviews; 147 had dementia. Dementia and its severity were diagnosed in accordance with Diagnostic and Statistical Manual of Mental Disorders (Third Edition, Revision [DSM-III-R]) criteria. Alzheimer disease according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria was diagnosed in 64 persons and vascular dementia (VaD) according to Erkinjuntti criteria was observed in 69. Fourteen had dementia due to other causes. Psychotic symptoms were classified according to DSM-III-R. The prevalence of psychotic symptoms in this very old population was 36% among AD cases compared to 54% in VaD cases (P = .04). Proportions with psychotic symptoms increased with increasing dementia severity in individuals with AD. No such association could be shown in those with VaD. This finding of a high proportion of psychotic symptoms also in individuals with mild severity of VaD should alert health professionals to evaluate dementia in very old patients who present with hallucinations or delusions.

Keywords

delusions hallucinations psychotic symptoms vascular dementia Alzheimer disease

Get full access to this article

View all access options for this article.

References

Ferri CP , Prince M. , Brayne C. , et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112-2117.

Henderson AS , Korten AE , Levings C. , et al. Psychotic symptoms in the elderly: a prospective study in a population sample. Int J Geriatr Psychiatry. 1998;13(7):484-492.

Matsumoto N. , Ikeda M. , Fukuhara R. , et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community . Dement Geriatr Cogn Disord . 2007;23(4):219-224.

Ballard C. , Oyebode F. Psychotic symptoms in patients with dementia. Int J Geriatr Psychiatry. 1995;10(9):743-752.

Ropacki SA , Jeste DV Epidemiology of and risk factors for psychosis of alzheimer’s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry . 2005;162(11):2022-2030.

Aalten P. , Verhey Fr , Boziki M. , et al. Neuropsychiatric syndromes in dementia. Results from the european alzheimer disease consortium: part I. Dement Geriatr Cogn Disord. 2007;24(6):457-463.

Wragg Re , Jeste Dv. Overview of depression and psychosis in alzheimer’s disease. Am J Psychiatry. 1989;146(5):577-587.

Groves WC , Brandt J. , Steinberg M. , et al. Vascular dementia and alzheimer’s disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci. 2000;12(3):305-315.

Lyketsos CG , Steinberg M. , Tschanz JT , et al. Mental and behavioral disturbances in dementia: findings from the cache county study on memory in aging. Am J Psychiatry . 2000;157(5):708-714.

10.

Lyketsos CG , Lopez O. , Jones B. , et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama. 2002;288(12):1475-1483.

11.

Skoog I. , Nilsson L. , Palmertz B. , Andreasson LA , Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med. 1993;328(3):153-158.

12.

Skoog I. , Nilsson L. , Landahl S. , Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr. 1993;5(1):33-48.

13.

Folstein MF , Robins LN , Helzer JE The mini-mental state examination. Arch Gen Psychiatry. 1983;40(7):812.

14.

Asberg Å M. , Montgomery SA , Perris C. , Schalling D. , Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl . 1978:(271):5-27.

15.

Landahl S. Drug treatment in 70-82-year-old persons. A longitudinal study. Acta Med Scand. 1987;221(2):179-184.

16.

ATC. Nordic council on medicines (1986) nordic statistics on medicines 198183. Guidlines for ATC classification. Vol 14. NLN Publication; 1986 Uppsala, Sweden.

17.

APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

18.

Ostling S. , Skoog I. Psychotic symptoms and paranoid ideation in a nondemented population- based sample of the very old. Arch Gen Psychiatry. 2002;59(1):53-59.

19.

Kane JW , Gowland E. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Clin Biochem. 1986; 23:509-513.

20.

Skoog I. , Hesse C. , Aevarsson O. , et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry. 1998; 64(1):37-43.

21.

APA. Diagnostic and statistical manual of mental disorders. 3rd ed., revised. Washington DC: American Psychiatric Association; 1987.

22.

Mckhann G. , Drachman D. , Folstein M. , Katzman R. , Price D. , Stadlan EM Clinical diagnosis of alzheimer’s disease: report of the nincds-adrda work group under the auspices of department of health and human services task force on alzheimer’s disease. Neurology. 1984;34(7):939-944.

23.

Erkinjuntti T. , Haltia M. , Palo J. , Sulkava R. , Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry. 1988;51(8):1037-1044.

24.

O’brien P. Comparing two samples; extension of the t, rank-sum and log-rank tests. J Am Stat Assoc. 1988;83(401):52-61.

25.

Leroi I. , Voulgari A. , Breitner JC , Lyketsos CG The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry . 2003; 11(1):83-91.

26.

Hughes CP , Berg L. , Danziger WL , Coben LA , et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-572.

27.

APA. Diagnostic and Statistical Manual of Mental disordes. 4th ed. Washington, DC: American Psychiatric Association; 2000.

28.

Ballard C. , Bannister C. , Graham C. , Oyebode F. , Wilcock G. Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry. 1995;167(4):537-540.

29.

Ostling S. , Palsson SP , Skoog I. The incidence of first-onset psychotic symptoms and paranoid ideation in a representative population sample followed from age 70-90 years. Relation to mortality and later development of dementia. Int J Geriatr Psychiatry . 2007;22(6):520-528.

30.

Binetti G. , Bianchetti A. , Padovani A. , Lenzi G. , De Leo D. , Trabucchi M. Delusions in alzheimer’s disease and multi-infarct dementia . Acta Neurol Scand. 1993;88(1):5-9.

31.

Flynn FG , Cummings JL , Gornbein J. Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. J Neuropsychiatry Clin Neurosci. 1991;3(4):364-370.

32.

Borroni B. , Agosti C. , Archetti S. , et al. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer disease. Neurosci Lett . 2004;370(2-3):127-129.

33.

Pritchard AL , Harris J. , Pritchard C. w, Coates J. , et al. Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer’s disease. Neurobiol Aging. 2008;29(3): 341-347.

34.

Pritchard AL , Pritchard CW , Bentham P. , Lendon CL Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable alzheimer disease patients. Dement Geriatr Cogn Disord . 2007 ;24(3):201-206.

35.

Borroni B. , Grassi M. , Agosti C. , et al. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging. 2006;27(11):1595-1603.

36.

Zdanys KF , Kleiman TG , Macavoy MG , Black BT , et al. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer’s disease. Neuropsychopharmacology . 2007;32(1): 171-179.

37.

Forsell Y. , Basun H. , Corder E. h, Lannfelt L. , Winblad B. Psychotic symptoms and apolipoprotein E genotypes in an elderly population . Biol Psychiatry. 1998;44(2):139-140.

38.

Serby M. , Samuels S. Visual hallucinations and dementia with lewy bodies. Arch Neurol. 2000;57(12):1792.